Ignite Creation Date:
2025-12-24 @ 4:06 PM
Ignite Modification Date:
2026-02-03 @ 6:34 AM
Study NCT ID:
NCT00748566
Status:
TERMINATED
Last Update Posted:
2021-03-03
First Post:
2008-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12
Start Date Type:
None
Primary Completion Date:
2012-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-05
First Submit QC Date:
None
Study First Post Date:
2008-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-29
Results First Submit QC Date:
None
Results First Post Date:
2013-06-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-02
Last Update Post Date:
2021-03-03
Last Update Post Date Type:
ACTUAL